BMO Capital analyst Sean Dodge upgraded HealthEquity (HQY) to Outperform from Market Perform with a price target of $105, up from $85. The firm says recent developments increase its conviction in HealthEquity’s longer-range growth outlook. AI fears around the company are overblown and provide investors with an attractive entry point, the analyst tells investors in a research note. BMO believes HealthEquity’s recent Marketplace launch establish a new, large, and high-margin growth opportunity.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HQY:
- HealthEquity Announces CTO Departure and Leadership Transition
- HealthEquity Chief Technology Officer to be terminated without cause
- HealthEquity Adds Sanford Health CEO Bill Gassen to Board
- HealthEquity price target raised to $128 from $120 at Deutsche Bank
- HealthEquity Inc. Earnings Call Highlights Profitable Growth